Osimertinib-Induced Cardiomyopathy

Osimertinib is the preferred treatment in patients with metastatic non–small cell lung cancer with epidermal growth factor receptor mutations. We report a case series of acute cardiomyopathy with heart failure exacerbation during osimertinib treatment. We suggest that cardiotoxicity from osimertinib...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:JACC Case Rep
Huvudupphovsmän: Patel, Shruti R., Brown, Sherry-Ann N., Kubusek, Jilan E., Mansfield, Aaron S., Duma, Narjust
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier 2020
Ämnen:
Case Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8298525/
https://ncbi.nlm.nih.gov/pubmed/34317311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaccas.2019.12.038
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk